📰 Early Phase News
Page 2 - Early Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Early Phase. Real-time updates on events, politics, business and more.
December 8, 2023
/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...
November 30, 2023
For some patients, CBD oil products have proven valuable in treating inflammation and lupus. Find out the best CBD oil for lupus in 2023.
November 15, 2023
In-person and webcast event on Sunday, 10 December, 2023 at 8:00 AM PT / 4:00 PM GMTReview of pooled analysis of the ongoing FELIX Phase Ib/II study, pooled analysis from ALLCAR19 and FELIX Phase Ib...
November 3, 2023
MARSEILLE, France--(BUSINESS WIRE)--Nov 3, 2023--
November 3, 2023
Poolbeg Pharma POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
November 3, 2023
Potential to address cancer treatment related Cytokine Release SyndromeLONDON, UK / ACCESSWIRE / November 3, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical
November 3, 2023
SAN DIEGO - Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the acceptance...
November 3, 2023
Poolbeg Pharma PLC Announces POLB 001 Data to be Presented at American ...
November 2, 2023
-- Oral Presentation Highlights Latest Clinical Findings from First Global, In-Human Phase 1/2 Dose-Escalation Study of Anti-CD7 Off-the-Shelf Allogeneic...